Salas Eduardo Rene 4
4 · Intra-Cellular Therapies, Inc. · Filed Apr 21, 2022
Insider Transaction Report
Form 4
Salas Eduardo Rene
Director
Transactions
- Award
Stock Option (right to buy)
2022-04-20+20,000→ 20,000 totalExercise: $60.03From: 2023-04-20Exp: 2032-04-20→ Common Stock (20,000 underlying)